170 related articles for article (PubMed ID: 38539166)
21. Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study.
Dinh A; Le Monnier A; Emery C; Alami S; Torreton É; Duburcq A; Barbier F
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1297-1305. PubMed ID: 30941532
[TBL] [Abstract][Full Text] [Related]
22. Clinical and Healthcare Burden of Multiple Recurrences of Clostridium difficile Infection.
Sheitoyan-Pesant C; Abou Chakra CN; Pépin J; Marcil-Héguy A; Nault V; Valiquette L
Clin Infect Dis; 2016 Mar; 62(5):574-580. PubMed ID: 26582748
[TBL] [Abstract][Full Text] [Related]
23. Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study.
Haubitz S; Bartlomé N; Bucheli Laffer E; Spelters C; Fankhauser H; Fux CA
Swiss Med Wkly; 2020 Jan; 150():w20173. PubMed ID: 31940431
[TBL] [Abstract][Full Text] [Related]
24. The burden of CDI in the United States: a multifactorial challenge.
Feuerstadt P; Theriault N; Tillotson G
BMC Infect Dis; 2023 Mar; 23(1):132. PubMed ID: 36882700
[TBL] [Abstract][Full Text] [Related]
25. Real-World Comparison of Bezlotoxumab to Standard of Care Therapy for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for Recurrence.
Johnson TM; Molina KC; Howard AH; Schwarz K; Allen L; Huang M; Bajrovic V; Miller MA
Clin Infect Dis; 2022 May; 74(9):1572-1578. PubMed ID: 34665248
[TBL] [Abstract][Full Text] [Related]
26. Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density.
Kimura T; Stanhope S; Sugitani T
J Infect Chemother; 2020 May; 26(5):438-443. PubMed ID: 32081648
[TBL] [Abstract][Full Text] [Related]
27. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC
Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924
[TBL] [Abstract][Full Text] [Related]
28. Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015-2020.
Okafor CM; Clogher P; Olson D; Niccolai L; Hadler J
Emerg Infect Dis; 2023 May; 29(5):877-87. PubMed ID: 37081745
[TBL] [Abstract][Full Text] [Related]
29. Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.
Blumberg EA; Collins G; Young JH; Nguyen MH; Michonneau D; Temesgen Z; Origȕen J; Barcan L; Obeid KM; Belloso WH; Gras J; Corbelli GM; Neaton JD; Lundgren J; Snydman DR; Molina JM;
Transpl Infect Dis; 2022 Feb; 24(1):e13770. PubMed ID: 34821423
[TBL] [Abstract][Full Text] [Related]
30. Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes.
Escudero-Sánchez R; Valencia-Alijo A; Cuéllar Tovar S; Merino-de Lucas E; García Fernández S; Gutiérrez-Rojas Á; Ramos-Martínez A; Salavert Lletí M; Castro Hernández I; Giner L; Cobo J
Infection; 2021 Jun; 49(3):475-482. PubMed ID: 33417171
[TBL] [Abstract][Full Text] [Related]
31. Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis.
Phatharacharukul P; Purpura RD; Gandhi D; Xu H; Bickett-Burkhart K; Chalasani N; Fischer M; Orman ES
Clin Transl Gastroenterol; 2020 Jul; 11(7):e00189. PubMed ID: 32675703
[TBL] [Abstract][Full Text] [Related]
32. Risk Factors for Recurrence of Clostridioides difficile in Hospitalized Patients.
Alrahmany D; Ereshefsky BJ; El Nekidy WS; Harb G; Pontiggia L; Ghazi IM
J Infect Public Health; 2021 Nov; 14(11):1642-1649. PubMed ID: 34627059
[TBL] [Abstract][Full Text] [Related]
33. Economic Impact of Recurrent Clostridioides difficile Infection in the USA: A Systematic Literature Review and Cost Synthesis.
Reveles KR; Yang M; Garcia-Horton V; Edwards ML; Guo A; Lodise T; Bochan M; Tillotson G; Dubberke ER
Adv Ther; 2023 Jul; 40(7):3104-3134. PubMed ID: 37210680
[TBL] [Abstract][Full Text] [Related]
34.
Pujol M; Limón E; Sopena N; Lopez-Contreras J; Castellá L; Cuquet J; López-Sánchez M; Pérez R; Gudiol C; Coloma A; Marimón M; Espinach J; Andres M; Martos P; Hernández S; Almendral A; Saliba P; Rodrigues GC; Calbo E; Group VP
Future Microbiol; 2022 Dec; 17():1445-1453. PubMed ID: 36314417
[No Abstract] [Full Text] [Related]
35. Clostridioides difficile infection in paediatric patients with cancer and haematopoietic stem cell transplant recipients.
Haeusler GM; Lehrnbecher T; Agyeman PKA; Loves R; Castagnola E; Groll AH; van de Wetering M; Aftandilian CC; Phillips B; Chirra KM; Schneider C; Dupuis LL; Sung L
Eur J Cancer; 2022 Aug; 171():1-9. PubMed ID: 35696884
[TBL] [Abstract][Full Text] [Related]
36. Mortality, healthcare resource utilization, and cost among Medicare beneficiaries with
Amin A; Nelson WW; Dreyfus J; Wong AC; Mohammadi I; Teigland C; Dahdal DN; Feuerstadt P
Ther Adv Infect Dis; 2022; 9():20499361221095679. PubMed ID: 35510091
[TBL] [Abstract][Full Text] [Related]
37. Temporal Gut Microbial Changes Predict Recurrent Clostridiodes Difficile Infection in Patients With and Without Ulcerative Colitis.
Lee AA; Rao K; Limsrivilai J; Gillilland M; Malamet B; Briggs E; Young VB; Higgins PDR
Inflamm Bowel Dis; 2020 Oct; 26(11):1748-1758. PubMed ID: 31971239
[TBL] [Abstract][Full Text] [Related]
38. Risk of complications and mortality following recurrent and non-recurrent Clostridioides difficile infection: a retrospective observational database study in England.
Enoch DA; Murray-Thomas T; Adomakoh N; Dedman D; Georgopali A; Francis NA; Karas A
J Hosp Infect; 2020 Dec; 106(4):793-803. PubMed ID: 32987118
[TBL] [Abstract][Full Text] [Related]
39. Clostridioides difficile infection in a long-term convalescence hospital: A real tale of pitfalls and outdated therapy.
Esteban-Rihuete M; Moreno-Borraz L; Rodríguez-Gascón D; García-Herrero JC; García-Lechuz JM; García-Forcada A
Rev Esp Quimioter; 2021 Feb; 34(1):51-55. PubMed ID: 33258362
[TBL] [Abstract][Full Text] [Related]
40. Excess length of hospital stay, mortality and cost attributable to
Kimura T; Stanhope S; Sugitani T
Epidemiol Infect; 2020 Mar; 148():e65. PubMed ID: 32115019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
